About the company
Burning Rock Biotech Ltd, a leading cancer diagnostics company, is revolutionizing the field of cancer detection and treatment. With their innovative products, such as OncoScreen Plus and ColonCore, they are making significant strides in improving patient outcomes. One of the key areas of focus for Burning Rock Biotech is tumor targeting. Through their cutting-edge technology, they have developed advanced methods to precisely identify cancerous cells. This level of accuracy allows for more effective and targeted treatment strategies for patients. In addition, Burning Rock Biotech has made significant advancements in differentiating between benign and malignant tumors. This capability is crucial in determining the appropriate course of action for patients. By accurately distinguishing between these two types of tumors, doctors can make informed decisions about treatment options, helping patients receive the most effective care. Another area of expertise for Burning Rock Biotech is the monitoring of small residual lesions. After cancer treatment, it is essential to closely monitor the patient for any signs of recurrence. The company's advanced monitoring techniques and technologies enable healthcare professionals to detect even the tiniest lesions, ensuring that the patient receives prompt and appropriate intervention if necessary. Furthermore, Burning Rock Biotech plays a vital role in predicting tumor recurrence progress. Through their extensive research and development efforts, they have created predictive models that can accurately estimate the likelihood and timeline of tumor recurrence. This information allows doctors to develop personalized treatment plans and closely monitor patients, increasing the chances of successful long-term outcomes. In addition to their diagnostic capabilities, Burning Rock Biotech offers a wide range of NGS-based cancer therapy selection tests. These tests cover various cancer types, including lung, gastrointestinal, prostate, breast, lymphomas, thyroid, colorectal, ovarian, pancreatic, and bladder cancers. Using both tissue and liquid biopsy samples, these tests provide invaluable insights into the genetic profiles of tumors, helping doctors determine the most appropriate and effective treatment options for patients. The company's commitment to advancing cancer detection and treatment is driven by their belief in the power of precision medicine. By analyzing the genetic makeup of tumors and tailoring treatment strategies accordingly, Burning Rock Biotech is leading the way in personalized cancer care. In conclusion, Burning Rock Biotech Ltd is at the forefront of cancer diagnostics, offering a range of innovative products and services that are transforming the way we detect and treat cancer. With their tumor targeting, differentiation, monitoring, prediction, and therapy selection capabilities, they are making great strides in improving patient outcomes. Through their dedication to precision medicine, Burning Rock Biotech is revolutionizing the field and giving hope to cancer patients worldwide.
Website: https://www.brbiotech.com
Data updated: June 2, 2026
